| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Erlotinib Hydrochloride | FAERS: 3 | OFFSIDES US FAERS | |
| 2 | PCI 32765 | FAERS: 3 | US FAERS | |
| 3 | Capecitabine | FAERS: 2 | US FAERS | |
| 4 | LCZ 696 | FAERS: 2 | US FAERS | |
| 5 | Alendronate | FAERS: 1 | US FAERS | |
| 6 | Azithromycin | FAERS: 1 | US FAERS | |
| 7 | Docetaxel | FAERS: 1 | US FAERS | |
| 8 | Gatifloxacin | FAERS: 1 | US FAERS | |
| 9 | Gefitinib | FAERS: 1 | US FAERS | |
| 10 | Lapatinib | FAERS: 1 | US FAERS | |
| 11 | Methylergonovine | FAERS: 1 | US FAERS | |
| 12 | Teriparatide | FAERS: 1 | US FAERS | |
| 13 | apremilast | FAERS: 1 | US FAERS | |
| 14 | Bupropion | OFFSIDES | ||
| 15 | Erlotinib Hydrochloride | OFFSIDES | ||
| 16 | Fosinopril | OFFSIDES | ||
| 17 | Paclitaxel | SIDER | ||
| 18 | Trimipramine | OFFSIDES | ||
| 19 | regorafenib | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.